{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:10:35Z","timestamp":1790266235129,"version":"4.1.0"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.tmaid.2020.101735","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:36:06Z","timestamp":1588786566000},"page":"101735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review"],"prefix":"10.1016","volume":"35","author":[{"given":"Anwar M.","family":"Hashem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrah S.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Algaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad S.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Alfaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2020.101735_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmaid.2020.101735_bib2","first-page":"1","article-title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","author":"Dhama","year":"2020","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2020.101735_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000149883","volume":"5","author":"Tyrrell","year":"1975","journal-title":"Coronaviridae. Intervirology"},{"key":"10.1016\/j.tmaid.2020.101735_bib4","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tmaid.2020.101735_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tmaid.2020.101735_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3201\/eid1404.071439","article-title":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany","volume":"14","author":"Gloza-Rausch","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1099\/00222615-6-2-177","article-title":"Further observations on the use of organ cultures in the study of acute respiratory-tract infections","volume":"6","author":"Higgins","year":"1973","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tmaid.2020.101735_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3181\/00379727-121-30734","article-title":"A new virus isolated from the human respiratory tract","volume":"121","author":"Hamre","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"Van der Hoek","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2020.101735_bib13","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2020.101735_bib15","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib17","article-title":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses \u2013 a statement of the Coronavirus Study Group","author":"Gorbalenya","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.tmaid.2020.101735_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.tmaid.2020.101735_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.tmaid.2020.101735_bib21","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2020.101735_bib22","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2020.101735_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J Gen Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib24","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1073\/pnas.78.6.3605","article-title":"Antihistaminics, local anesthetics, and other amines as antiviral agents","volume":"78","author":"Miller","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmaid.2020.101735_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01250299","article-title":"Effect of chloroquine on the growth of animal viruses","volume":"36","author":"Shimizu","year":"1972","journal-title":"Arch Gesamte Virusforsch"},{"key":"10.1016\/j.tmaid.2020.101735_bib26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib27","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612043383791","article-title":"Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity","volume":"10","author":"Romanelli","year":"2004","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.tmaid.2020.101735_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.72.1.783-788.1998","article-title":"Mechanism of Borna disease virus entry into cells","volume":"72","author":"Gonzalez-Dunia","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib31","doi-asserted-by":"crossref","first-page":"12634","DOI":"10.1128\/JVI.76.24.12634-12645.2002","article-title":"Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction","volume":"76","author":"Ros","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib32","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1128\/JVI.76.24.12866-12876.2002","article-title":"Endocytosis is a critical step in entry of subgroup B avian leukosis viruses","volume":"76","author":"Diaz-Griffero","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000024948","article-title":"Examination of potential inhibitors of hepatitis A virus uncoating","volume":"41","author":"Bishop","year":"1998","journal-title":"Intervirology"},{"key":"10.1016\/j.tmaid.2020.101735_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1099\/0022-1317-49-4-313","article-title":"Weak bases affect late stages of Mayaro virus replication cycle in vertebrate cells","volume":"49","author":"Ferreira","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tmaid.2020.101735_bib35","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/JVI.75.3.1236-1251.2001","article-title":"Characterization of herpes simplex virus-containing organelles by subcellular fractionation: role for organelle acidification in assembly of infectious particles","volume":"75","author":"Harley","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib36","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/bi035923w","article-title":"Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines","volume":"43","author":"Kwiek","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.tmaid.2020.101735_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.tmaid.2020.101735_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.tmaid.2020.101735_bib39","doi-asserted-by":"crossref","first-page":"E8508","DOI":"10.1073\/pnas.1712592114","article-title":"Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmaid.2020.101735_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tmaid.2020.101735_bib41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells","volume":"82","author":"Khan","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib42","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.tmaid.2020.101735_bib44","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1074\/jbc.M110.151324","article-title":"Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis","volume":"286","author":"Carew","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmaid.2020.101735_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(11)70092-5","article-title":"Use of chloroquine in viral diseases","volume":"11","author":"Savarino","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11427-009-0061-0","article-title":"Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis","volume":"52","author":"Wang","year":"2009","journal-title":"Sci China C Life Sci"},{"key":"10.1016\/j.tmaid.2020.101735_bib47","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2014.12.FOCUS14748","article-title":"Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors","volume":"38","author":"Golden","year":"2015","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.tmaid.2020.101735_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-017-1393-y","article-title":"Hydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling","volume":"19","author":"Wu","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.tmaid.2020.101735_bib49","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/348600a0","article-title":"Intracellular transport of class II MHC molecules directed by invariant chain","volume":"348","author":"Lotteau","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2020.101735_bib51","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.tmaid.2020.101735_bib52","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature07405","article-title":"The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor","volume":"456","author":"Ewald","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2020.101735_bib53","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1093\/emboj\/17.21.6230","article-title":"CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation","volume":"17","author":"Hacker","year":"1998","journal-title":"Embo j"},{"key":"10.1016\/j.tmaid.2020.101735_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.tmaid.2020.101735_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00124743-199804000-00004","article-title":"Antimalarial ocular toxicity a critical appraisal","volume":"4","author":"Albert","year":"1998","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1983.tb01532.x","article-title":"Disposition of chloroquine in man after single intravenous and oral doses","volume":"15","author":"Gustafsson","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101735_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0961203396005001041","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases","volume":"5","author":"Furst","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.tmaid.2020.101735_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"Tett","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101735_bib59","series-title":"Antirheumatic therapy: actions and outcomes","first-page":"81","article-title":"Hydroxychloroquine","author":"Bothwell","year":"2005"},{"key":"10.1016\/j.tmaid.2020.101735_bib60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0950-3579(05)80004-4","article-title":"Antimalarials in rheumatic diseases","volume":"4","author":"Tett","year":"1990","journal-title":"Bailliere\u2019s Clin Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-199631040-00003","article-title":"Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements","volume":"31","author":"Ducharme","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.tmaid.2020.101735_bib62","first-page":"142","article-title":"Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials","volume":"24","author":"Cutler","year":"1988","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.tmaid.2020.101735_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.tmaid.2020.101735_bib64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1442-9071.1987.tb00097.x","article-title":"Melanin: blackguard or red herring? Another look at chloroquine retinopathy","volume":"15","author":"Banks","year":"1987","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.tmaid.2020.101735_bib65","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00542151","article-title":"The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects","volume":"26","author":"Frisk-Holmberg","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101735_bib66","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2125.1995.tb05731.x","article-title":"The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis","volume":"39","author":"Wetsteyn","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101735_bib67","first-page":"E162","article-title":"Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM","volume":"265","author":"Hovorka","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.tmaid.2020.101735_bib68","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/rcm.5021","article-title":"Distribution of chloroquine in ocular tissue of pigmented rat using matrix-assisted laser desorption\/ionization imaging quadrupole time-of-flight tandem mass spectrometry","volume":"25","author":"Yamada","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.tmaid.2020.101735_bib69","series-title":"Antimalarial drug II: current antimalarial and New drug developments","first-page":"3","author":"McChesney","year":"1984"},{"key":"10.1016\/j.tmaid.2020.101735_bib70","first-page":"292","article-title":"Ocular safety of hydroxychloroquine","volume":"23","author":"Bernstein","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.tmaid.2020.101735_bib71","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI101980","article-title":"Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalaril activity, and toxicity of several derivatives of 4-aminoquinoline","volume":"27","author":"Berliner","year":"1948","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmaid.2020.101735_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007691-198907000-00001","article-title":"Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine","volume":"11","author":"Titus","year":"1989","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.tmaid.2020.101735_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","article-title":"Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","article-title":"Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate","volume":"75","author":"McChesney","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.tmaid.2020.101735_bib75","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0049-0172(10)80011-3","article-title":"Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine","volume":"23","author":"Iredale","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.tmaid.2020.101735_bib76","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2165\/00003088-200342150-00004","article-title":"Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs","volume":"42","author":"Brocks","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.tmaid.2020.101735_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/jop.1994.10.217","article-title":"Relevance of drug-melanin interactions to ocular pharmacology and toxicology","volume":"10","author":"Salazar-Bookaman","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101735_bib78","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/art.10307","article-title":"Hydroxychloroquine concentration\u2013response relationships in patients with rheumatoid arthritis","volume":"46","author":"Munster","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tmaid.2020.101735_bib79","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.tmaid.2020.101735_bib80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2230.2001.00857-3.x","article-title":"Fatal toxic epidermal necrolysis associated with hydroxychloroquine","volume":"26","author":"Murphy","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"Chen","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.tmaid.2020.101735_bib82","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.ijcard.2007.04.055","article-title":"Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine","volume":"127","author":"Stas","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tmaid.2020.101735_bib83","article-title":"The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine\/azithromycin","author":"Chorin","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.tmaid.2020.101735_bib84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4269\/ajtmh.1957.6.654","article-title":"Reactions to chloroquine observed during the treatment of various dermatologic disorders","volume":"6","author":"Goldman","year":"1957","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101735_bib85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","article-title":"New insights into mechanisms of therapeutic effects of antimalarial agents in SLE","volume":"8","author":"Wallace","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0049-0172(78)90033-1","article-title":"Antimalarials in the management of discoid and systemic lupus erythematosus","volume":"8","author":"Dubois","year":"1978","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.tmaid.2020.101735_bib87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib88","first-page":"294","article-title":"Ocular toxicity of hydroxychloroquine","volume":"12","author":"Yam","year":"2006","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.tmaid.2020.101735_bib89","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0161-6420(03)00409-3","article-title":"The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal","volume":"110","author":"Mavrikakis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tmaid.2020.101735_bib90","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archophthalmol.2010.321","article-title":"Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy","volume":"129","author":"Michaelides","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.tmaid.2020.101735_bib91","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib92","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1378\/chest.06-1146","article-title":"Hydroxychloroquine-Induced toxic myopathy causing respiratory failure","volume":"131","author":"Siddiqui","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.tmaid.2020.101735_bib93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/RHU.0b013e3181c47ec8","article-title":"Hydroxychloroquine-Induced myopathy","volume":"16","author":"Kwon","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib94","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mus.21091","article-title":"Severe hydroxychloroquine myopathy","volume":"38","author":"Abdel-Hamid","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tmaid.2020.101735_bib95","first-page":"523","article-title":"[Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports]","volume":"36","author":"Becerra-Cu\u00f1at","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.tmaid.2020.101735_bib96","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.humpath.2007.06.013","article-title":"New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy\u2014a report of 2 cases","volume":"38","author":"Soong","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.tmaid.2020.101735_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.euje.2006.02.002","article-title":"Hydroxychloroquine-induced restrictive cardiomyopathy: correlation between clinical, Echocardiographic and pathologic findings","volume":"8","author":"Cotroneo","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.tmaid.2020.101735_bib98","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIRCHEARTFAILURE.110.959916","article-title":"Hydroxychloroquine-induced cardiomyopathy: a case report","volume":"4","author":"Muthukrishnan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.tmaid.2020.101735_bib99","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.4103\/jfmpc.jfmpc_413_19","article-title":"Chloroquine induced urticaria: a newer adverse effect","volume":"8","author":"Balamurugesan","year":"2019","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.tmaid.2020.101735_bib100","first-page":"472","article-title":"Ototoxicity due to hydroxychloroquine: report of two cases","volume":"16","author":"Johansen","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101735_bib101","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002960000054","article-title":"Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis","volume":"19","author":"Seckin","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.tmaid.2020.101735_bib102","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/MJT.0b013e31802e4b0e","article-title":"Chloroquine-induced recurrent psychosis","volume":"14","author":"Sahoo","year":"2007","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.tmaid.2020.101735_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002960000066","article-title":"Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus","volume":"20","author":"Malcangi","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.tmaid.2020.101735_bib104","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tmaid.2020.101735_bib105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.tmaid.2020.101735_bib106","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0601856","article-title":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities","volume":"49","author":"Biot","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.tmaid.2020.101735_bib107","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"De Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2020.101735_bib108","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2020.101735_bib109","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2007.10.011","article-title":"Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK","volume":"77","author":"Kono","year":"2008","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2013.04.016","article-title":"Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo","volume":"99","author":"Takano","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib111","first-page":"56","article-title":"Induction of atypical autophagy by porcine hemagglutinating encephalomyelitis virus contributes to viral replication","volume":"7","author":"Ding","year":"2017","journal-title":"Front cell infect microbol"},{"key":"10.1016\/j.tmaid.2020.101735_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib113","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-019-0132-8","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell discov"},{"key":"10.1016\/j.tmaid.2020.101735_bib115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0042-6822(66)90046-8","article-title":"Effect of chloroquine on lysosomes and on growth of mouse hepatitis virus (MHV-3)","volume":"28","author":"Mallucci","year":"1966","journal-title":"Virology"},{"key":"10.1016\/j.tmaid.2020.101735_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194868","article-title":"MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells","volume":"13","author":"Cong","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101735_bib117","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/jvi.65.4.1916-1928.1991","article-title":"Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein","volume":"65","author":"Gallagher","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib118","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/aid.1990.6.481","article-title":"Inhibition of human immunodeficiency virus infectivity by chloroquine","volume":"6","author":"Tsai","year":"1990","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.tmaid.2020.101735_bib119","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(05)60566-1","article-title":"Antiretroviral treatment","volume":"352","author":"Boelaert","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2020.101735_bib120","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1089\/088922299310133","article-title":"Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea","volume":"15","author":"Boelaert","year":"1999","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.tmaid.2020.101735_bib121","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0006-2952(01)00576-7","article-title":"The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea","volume":"61","author":"Boelaert","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101735_bib122","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00126334-200403010-00002","article-title":"Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors","volume":"35","author":"Savarino","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tmaid.2020.101735_bib123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/aid.1993.9.91","article-title":"Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes","volume":"9","author":"Sperber","year":"1993","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.tmaid.2020.101735_bib124","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0149-2918(96)80063-4","article-title":"Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine","volume":"18","author":"Chiang","year":"1996","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.tmaid.2020.101735_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006249","article-title":"Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1\/TRIM28 in Burkitt lymphoma cells","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tmaid.2020.101735_bib126","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.tmaid.2020.101735_bib127","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/jvi.43.1.284-293.1982","article-title":"Infectious cell entry mechanism of influenza virus","volume":"43","author":"Yoshimura","year":"1982","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-3-39","article-title":"In vitro inhibition of human influenza A virus replication by chloroquine","volume":"3","author":"Ooi","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.tmaid.2020.101735_bib129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1750-2659.2007.00027.x","article-title":"Chloroquine is effective against influenza A virus in vitro but not in vivo","volume":"1","author":"Vigerust","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.tmaid.2020.101735_bib130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-4-39","article-title":"Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses","volume":"4","author":"Di Trani","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.tmaid.2020.101735_bib131","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1099\/0022-1317-64-5-1149","article-title":"Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine","volume":"64","author":"Shibata","year":"1983","journal-title":"J Gen Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib132","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1371\/journal.ppat.0030089","article-title":"Characterization of reemerging chikungunya virus","volume":"3","author":"Sourisseau","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tmaid.2020.101735_bib133","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/v10050268","article-title":"Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection","volume":"10","author":"Roques","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2020.101735_bib134","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","article-title":"Chloroquine, a FDA-approved drug, prevents zika virus infection and its associated congenital microcephaly in mice","volume":"24","author":"Li","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tmaid.2020.101735_bib135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an endocytosis blocking agent, inhibits zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2020.101735_bib136","doi-asserted-by":"crossref","first-page":"15771","DOI":"10.1038\/s41598-017-15467-6","article-title":"Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis","volume":"7","author":"Shiryaev","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmaid.2020.101735_bib137","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1099\/jgv.0.000309","article-title":"Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo Guinea pig model","volume":"96","author":"Dowall","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib138","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3201\/eid2106.150176","article-title":"Lack of protection against ebola virus from chloroquine in mice and hamsters","volume":"21","author":"Falzarano","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101735_bib140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1348-0421.12154","article-title":"Chloroquine interferes with dengue-2 virus replication in U937 cells","volume":"58","author":"Farias","year":"2014","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.tmaid.2020.101735_bib141","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1155\/2013\/282734","article-title":"Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6\/36 cells","volume":"2013","author":"Farias","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.tmaid.2020.101735_bib142","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/jvi.37.3.1060-1065.1981","article-title":"Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus","volume":"37","author":"Coombs","year":"1981","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib143","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01310010","article-title":"Ammonium chloride and chloroquine inhibit rabies virus infection in neuroblastoma cells. Brief report","volume":"81","author":"Tsiang","year":"1984","journal-title":"Arch Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib144","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00535-009-0132-9","article-title":"Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy","volume":"45","author":"Mizui","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.tmaid.2020.101735_bib145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jmv.1890310205","article-title":"Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds","volume":"31","author":"Civitico","year":"1990","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib146","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0042-6822(91)90157-7","article-title":"Inhibition of duck hepatitis B virus infection by lysosomotropic agents","volume":"183","author":"Offensperger","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.tmaid.2020.101735_bib147","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01313817","article-title":"Early events in arenavirus replication are sensitive to lysosomotropic compounds","volume":"104","author":"Glushakova","year":"1989","journal-title":"Arch Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib148","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/vir.0.017269-0","article-title":"Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection","volume":"91","author":"Freiberg","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib149","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1128\/JVI.00903-12","article-title":"Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway","volume":"86","author":"Zhu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2015.03.005","article-title":"Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules","volume":"118","author":"Ferraris","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib151","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1128\/jvi.65.12.7008-7011.1991","article-title":"Chloroquine induces empty capsid formation during poliovirus eclipse","volume":"65","author":"Kronenberger","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib152","doi-asserted-by":"crossref","first-page":"104646","DOI":"10.1016\/j.antiviral.2019.104646","article-title":"Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice","volume":"173","author":"Niu","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101735_bib153","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1128\/JVI.01847-09","article-title":"Chloroquine administration does not prevent Nipah virus infection and disease in ferrets","volume":"83","author":"Pallister","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib154","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/jvi.65.2.992-995.1991","article-title":"Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice","volume":"65","author":"Maheshwari","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101735_bib155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","article-title":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial","volume":"11","author":"Paton","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib156","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib157","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib158","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1590\/S0074-02762013000500010","article-title":"Chloroquine use improves dengue-related symptoms","volume":"108","author":"Borges","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.tmaid.2020.101735_bib159","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0149-2918(97)80045-8","article-title":"Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1","volume":"19","author":"Sperber","year":"1997","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.tmaid.2020.101735_bib160","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1089\/aid.2015.0336","article-title":"The effect of chloroquine on immune activation and interferon signatures associated with HIV-1","volume":"32","author":"Jacobson","year":"2016","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.tmaid.2020.101735_bib161","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2012.6936","article-title":"Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial","volume":"308","author":"Paton","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2020.101735_bib162","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2020.101735_bib163","first-page":"20040758","article-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.tmaid.2020.101735_bib164","doi-asserted-by":"crossref","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study","author":"Gautret","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101735_bib165","article-title":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)","volume":"49","author":"Chen","year":"2020","journal-title":"J Zhejiang Univ - Sci A"},{"key":"10.1016\/j.tmaid.2020.101735_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","author":"Molina","year":"2020","journal-title":"Med Maladies Infect"},{"key":"10.1016\/j.tmaid.2020.101735_bib167","doi-asserted-by":"crossref","first-page":"m1335","DOI":"10.1136\/bmj.m1335","article-title":"Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence","volume":"369","author":"Lenzer","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.tmaid.2020.101735_bib168","author":"Indian Council for Medical Research"},{"key":"10.1016\/j.tmaid.2020.101735_bib169","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.1780390122","article-title":"The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis","volume":"39","author":"Ornstein","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tmaid.2020.101735_bib170","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0149-2918(95)80039-5","article-title":"Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1","volume":"17","author":"Sperber","year":"1995","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.tmaid.2020.101735_bib171","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1089\/aid.2015.0336","article-title":"The effect of chloroquine on immune activation and interferon signatures associated with HIV-1","volume":"32","author":"Jacobson","year":"2016","journal-title":"AIDS Res Hum Retrovir"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920302143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920302143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:05:39Z","timestamp":1761487539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893920302143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":171,"alternative-id":["S1477893920302143"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101735","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101735"}}